Masayuki Ishihara

975 total citations
32 papers, 696 citations indexed

About

Masayuki Ishihara is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Masayuki Ishihara has authored 32 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Nephrology and 6 papers in Surgery. Recurrent topics in Masayuki Ishihara's work include Neonatal Health and Biochemistry (3 papers), Viral-associated cancers and disorders (3 papers) and Parathyroid Disorders and Treatments (2 papers). Masayuki Ishihara is often cited by papers focused on Neonatal Health and Biochemistry (3 papers), Viral-associated cancers and disorders (3 papers) and Parathyroid Disorders and Treatments (2 papers). Masayuki Ishihara collaborates with scholars based in Japan, Greece and Nepal. Masayuki Ishihara's co-authors include Yoshio Terada, Kosuke Inoue, Koji Ogata, Shimpei Fujimoto, Yoshiko Shimamura, Kazu Hamada, Taro Horino, Yoshinori Taniguchi, Mikiya Fujieda and Tatsuki Matsumoto and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Physiology-Renal Physiology.

In The Last Decade

Masayuki Ishihara

29 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Ishihara Japan 10 247 230 136 99 89 32 696
Diana Zepeda‐Orozco United States 14 412 1.7× 260 1.1× 108 0.8× 131 1.3× 143 1.6× 30 905
Zhixia Song China 15 262 1.1× 220 1.0× 92 0.7× 160 1.6× 111 1.2× 21 710
Ning An China 17 280 1.1× 132 0.6× 108 0.8× 88 0.9× 57 0.6× 67 792
Yinyin Chen China 15 225 0.9× 100 0.4× 88 0.6× 89 0.9× 76 0.9× 33 563
Naijun Miao China 18 434 1.8× 210 0.9× 81 0.6× 80 0.8× 73 0.8× 21 807
Hüseyin Kayadibi Türkiye 13 152 0.6× 72 0.3× 170 1.3× 58 0.6× 99 1.1× 51 559
Zhi Zhao China 17 418 1.7× 231 1.0× 51 0.4× 87 0.9× 87 1.0× 40 912
Yaping Fan China 17 254 1.0× 116 0.5× 56 0.4× 32 0.3× 114 1.3× 40 626
Mustafa Ünal Türkiye 19 214 0.9× 58 0.3× 63 0.5× 50 0.5× 103 1.2× 73 1.1k
Qian Ge China 17 276 1.1× 47 0.2× 148 1.1× 38 0.4× 85 1.0× 59 878

Countries citing papers authored by Masayuki Ishihara

Since Specialization
Citations

This map shows the geographic impact of Masayuki Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Ishihara more than expected).

Fields of papers citing papers by Masayuki Ishihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Ishihara. The network helps show where Masayuki Ishihara may publish in the future.

Co-authorship network of co-authors of Masayuki Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Ishihara. A scholar is included among the top collaborators of Masayuki Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Ishihara. Masayuki Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hattori, Naoki, et al.. (2024). Macroprolactin in mothers and their babies: what is its origin?. Clinical Chemistry and Laboratory Medicine (CCLM). 62(11). 2162–2168. 1 indexed citations
4.
Horino, Taro, Masayuki Ishihara, & Mikiya Fujieda. (2023). Urinary 2,8-dihydroxyadenine crystals in a patient with adenine phosphoribosyltransferase deficiency. QJM. 116(10). 855–856. 1 indexed citations
5.
Kohara, Nobuo, Shinji Sato, Masataka Nakamura, et al.. (2023). Visualization of axonal and volume currents in median nerve compound action potential using magnetoneurography. Clinical Neurophysiology. 152. 57–67. 1 indexed citations
6.
Ishihara, Masayuki, et al.. (2021). The first case report of Kocuria rhizophila peritonitis in a 3‐year‐old Japanese girl. Pediatrics International. 63(12). 1523–1524. 5 indexed citations
7.
Horino, Taro, et al.. (2021). Immunotactoid glomerulopathy associated with monoclonal gammopathy. The Lancet. 397(10289). 2081–2081. 4 indexed citations
8.
Takahashi, Ippei, et al.. (2018). Common carotid arteritis and polymyalgia with Mycoplasma pneumoniae infection. Journal of Infection and Chemotherapy. 25(4). 281–284. 5 indexed citations
9.
Matsumoto, Tatsuki, Masayuki Ishihara, Yoshiko Shimamura, et al.. (2015). Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury. PLoS ONE. 10(5). e0126229–e0126229. 62 indexed citations
10.
Ishihara, Masayuki, Kazu Hamada, Tatsuki Matsumoto, et al.. (2013). Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. American Journal of Physiology-Renal Physiology. 305(4). F495–F509. 177 indexed citations
11.
Miura, Kenichiro, Takashi Sekine, Kazuhiro Takahashi, et al.. (2013). Mutational analyses of the ATP6V1B1 and ATP6V0A4 genes in patients with primary distal renal tubular acidosis. Nephrology Dialysis Transplantation. 28(8). 2123–2130. 22 indexed citations
12.
Hamada, Kazu, Yoshinori Taniguchi, Yoshiko Shimamura, et al.. (2013). Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease. Clinical and Experimental Nephrology. 17(6). 848–856. 75 indexed citations
13.
Terada, Yoshio, Keiji Inoue, Tatsuki Matsumoto, et al.. (2013). 5-Aminolevulinic Acid Protects against Cisplatin-Induced Nephrotoxicity without Compromising the Anticancer Efficiency of Cisplatin in Rats In Vitro and In Vivo. PLoS ONE. 8(12). e80850–e80850. 42 indexed citations
14.
Shimamura, Yoshiko, Kazu Hamada, Kosuke Inoue, et al.. (2012). Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clinical and Experimental Nephrology. 16(5). 722–729. 152 indexed citations
15.
Ishihara, Masayuki, Eriko Tanaka, Takao Sato, et al.. (2011). Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients. Clinical Nephrology. 76(7). 40–48. 18 indexed citations
16.
Tanaka, Eriko, Tetsuya Sato, Masayuki Ishihara, et al.. (2011). Asymptomatic high Epstein–Barr viral load carriage in pediatric renal transplant recipients. Pediatric Transplantation. 15(3). 306–313. 24 indexed citations
17.
Fujieda, Mikiya, Keishi Naruse, Yoshihiro Hayashi, et al.. (2010). Effect of pravastatin on cisplatin-induced nephrotoxicity in rats. Human & Experimental Toxicology. 30(7). 603–615. 9 indexed citations
18.
Yura, Hirofumi, Masayuki Ishihara, Shingo Nakamura, et al.. (2009). Coatings of Low‐Density Lipoprotein and Synthetic Glycoconjugates as Substrata for Hepatocytes. Artificial Organs. 33(6). 419–424. 1 indexed citations
19.
Ishihara, Masayuki, et al.. (2006). Idiopathic thrombocytopenic purpura associated with Helicobacter pylori infection. Pediatrics International. 48(1). 76–78. 3 indexed citations
20.
Ishihara, Masayuki, Katsuaki Ono, Yuichi Ozeki, et al.. (2002). NON-ANTICOAGULANT HEPARIN-CARRYING POLYSTYRENE (NAC-HCPS) AFFECTS ANGIOGENESIS AND INHIBITS SUBCUTANEOUS INDUCED TUMOR GROWTH AND METASTASIS TO THE LUNG.. 34(1). 70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026